Macropinocytosis and SARS-CoV-2 cell entry

doi: 10.46701/BG.2021012021110

• Xiaowei Sun^{1, △} , 
• Wenyue Zheng¹ , 
• Rui Hua¹ , 
• Yujie Liu¹ , 
• Li Wang¹ , 
• Yun-Gi Kim² , 
• Xinqi Liu³ , 
• Hitomi Mimuro⁴ , 
• Zhongyang Shen^{5, 6 ,  ,}  , 
• Lian Li^{1 ,  ,}  , 
• Sei Yoshida^{1, 5, 7 ,  ,} 

• 1.

  State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Frontiers Science Center for Cell Responses, Nankai University, Tianjin 300071, China

• 2.

  Research Center for Drug Discovery, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Minato-Ku, Tokyo 105-8512, Japan

• 3.

  State Key Laboratory of Medicinal Chemical Biology, Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin 300071, China

• 4.

  Department of Infection Microbiology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan

• 5.

  Organ Transplant Department, Tianjin First Central Hospital, Tianjin 300192, China

• 6.

  NHC Key Laboratory of Critical Care Medicine, Tianjin First Central Hospital, Tianjin 300192, China

• 7.

  Research Institute of Transplant Medicine, Nankai University, Tianjin 300071, China